[HTML][HTML] An updated systematic review on focal therapy in localized prostate cancer: what has changed over the past 5 years?

JS Hopstaken, JGR Bomers, MJP Sedelaar, M Valerio… - European Urology, 2022‏ - Elsevier
Context Focal therapy is a promising, minimally invasive strategy to selectively treat
localized prostate cancer. A previous systematic review indicated that there is growing …

French AFU Cancer Committee Guidelines-Update 2022-2024: prostate cancer-Diagnosis and management of localised disease

G Ploussard, G Fiard, E Barret, L Brureau… - Progrès en Urologie, 2022‏ - Elsevier
Objective The objective of the French Urology Association Cancer Committee is to propose
an update of the recommendations for the diagnosis and management of prostate cancer …

Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study

AR Rastinehad, H Anastos, E Wajswol… - Proceedings of the …, 2019‏ - pnas.org
Biocompatible gold nanoparticles designed to absorb light at wavelengths of high tissue
transparency have been of particular interest for biomedical applications. The ability of such …

[HTML][HTML] Focal therapy: patients, interventions, and outcomes—a report from a consensus meeting

IA Donaldson, R Alonzi, D Barratt, E Barret, V Berge… - European urology, 2015‏ - Elsevier
Background Focal therapy as a treatment option for localized prostate cancer (PCa) is an
increasingly popular and rapidly evolving field. Objective To gather expert opinion on patient …

Focal therapy in primary localised prostate cancer: the European Association of Urology position in 2018

HG van der Poel, RCN van den Bergh, E Briers… - European urology, 2018‏ - Elsevier
Radical treatment of localised prostate cancer is recognised to be an unnecessary
intervention or overtreatment in many men. Consequently, there has been a rapid uptake in …

Early-medium-term outcomes of primary focal cryotherapy to treat nonmetastatic clinically significant prostate cancer from a prospective multicentre registry

TT Shah, M Peters, D Eldred-Evans, S Miah, T Yap… - European urology, 2019‏ - Elsevier
Background Focal cryotherapy can be used to treat patients with clinically significant
nonmetastatic prostate cancer to reduce side effects. Objective Early-medium-term cancer …

Focal high-intensity focused ultrasound targeted hemiablation for unilateral prostate cancer: a prospective evaluation of oncologic and functional outcomes

ERC Feijoo, A Sivaraman, E Barret, R Sanchez-Salas… - European urology, 2016‏ - Elsevier
Background In selected patients with unilateral, organ-confined prostate cancer (PCa),
hemiablation of the affected lobe might be feasible to achieve acceptable cancer control with …

Oncological results and cancer control definition in focal therapy for prostate cancer: a systematic review

R Nicoletti, A Alberti, D Castellani, CH Yee… - Prostate Cancer and …, 2024‏ - nature.com
Introduction Focal therapy (FT) is a promising alternative to whole-gland treatments for
Localized Prostate Cancer. Ten different FT modalities have been described in literature …

Prostate specific membrane antigen positron emission tomography may improve the diagnostic accuracy of multiparametric magnetic resonance imaging in localized …

H Rhee, P Thomas, B Shepherd, S Gustafson… - The Journal of …, 2016‏ - auajournals.org
Purpose: Positron emission tomography using ligands targeting prostate specific membrane
antigen has recently been introduced. Positron emission tomography imaging with 68Ga …

Improved specificity with 68Ga PSMA PET/CT to detect clinically significant lesions “invisible” on multiparametric MRI of the prostate: a single institution comparative …

P Donato, MJ Roberts, A Morton, S Kyle… - European journal of …, 2019‏ - Springer
Purpose Positron emission tomography (PET) for prostate-specific membrane antigen
(PSMA) represents a promising method for prostate cancer diagnosis and staging …